Skip to content

Hypoglycemia and Diabetic Emergencies Reference

Hypoglycemia is a glucose level low enough to require action. It is common in people who use insulin and can progress from autonomic warning symptoms to impaired thinking, seizure, loss of consciousness, coma, or death. Severe events are defined by the person’s need for help, not by one universal glucose number.

Diabetes can also cause emergencies from insufficient insulin and high glucose. Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are distinct from hypoglycemia and require different treatment.

Hypoglycemia levels

Current clinical classification uses three levels:

  • Level 1: glucose below 70 mg/dL and at least 54 mg/dL. This is the alert range and requires prompt action.
  • Level 2: glucose below 54 mg/dL. This is clinically significant hypoglycemia and requires immediate treatment.
  • Level 3: altered mental or physical function severe enough that another person is needed for recovery, regardless of the measured glucose value.

The same number can affect two people differently, and the same person may respond differently depending on rate of decline, recent glucose patterns, sleep, illness, medication, alcohol, or other physiological stress. A person can be conscious at a very low value or need assistance at a higher one. The phrase “diabetic coma” describes an outcome, not a diagnostic glucose threshold.

Causes and risk

For a person using insulin, hypoglycemia can follow:

  • more insulin than the body needs at that time;
  • a delayed, smaller, or missed meal;
  • vomiting or reduced absorption after insulin has been given;
  • physical activity during or for hours after exertion;
  • alcohol, especially without food;
  • illness, heat, altitude, hormonal change, or an unexpected routine shift;
  • an insulin-pump or dosing error; or
  • changing insulin sensitivity during stress or recovery.

Stress hormones may raise glucose in one situation and falling glucose may follow exertion or reduced intake in another. An adrenaline drop after a crisis does not by itself establish the cause of a low. The insulin on board, food intake, activity, glucose trend, and medical context all matter.

Repeated hypoglycemia can reduce warning awareness in some people. Medications and neurological or autonomic conditions can also alter how symptoms are perceived. Continuous glucose monitoring adds an external warning system but does not eliminate risk.

Symptoms

Early autonomic symptoms may include shaking, sweating, hunger, tingling, pallor, anxiety, irritability, and a rapid heartbeat. Neuroglycopenic symptoms arise as the brain receives insufficient glucose and may include:

  • slowed processing or unusual silence;
  • confusion or behavior that resembles intoxication;
  • difficulty finding words or slurred speech;
  • blurred vision;
  • poor coordination or weakness;
  • inability to follow a familiar treatment sequence;
  • seizure; or
  • loss of consciousness.

Symptoms do not always occur in a fixed order. A person with reduced warning awareness may become cognitively impaired before recognizing the low.

Immediate treatment

An alert person who can safely swallow can use fast-acting glucose or another rapidly absorbed carbohydrate. A common starting approach is approximately fifteen grams followed by a glucose recheck after fifteen minutes, although automated-insulin-delivery users and children may have individualized amounts. Treatment is repeated if the low persists. Fat- or protein-heavy foods absorb too slowly for the initial correction, although a longer-lasting snack or meal may follow after recovery when appropriate.

Nothing should be placed in the mouth of a person who is unconscious, seizing, unable to swallow, or too confused to cooperate. A support person should administer prescribed glucagon, call emergency services, protect the person from injury, and follow the product’s instructions. Ready-to-use injection and nasal glucagon reduce the number of steps compared with older reconstitution kits. A person does not need to be a clinician to give glucagon after training.

Medical treatment may include intravenous dextrose, repeated glucose checks, airway or seizure management, and evaluation of the cause. A Level 2 or Level 3 event should prompt review of insulin delivery, glucose patterns, technology, food and activity timing, warning awareness, and the emergency plan.

Continuous monitoring and preparation

A continuous glucose monitor (CGM) measures glucose in interstitial fluid and displays current estimates, trends, and alerts. Because interstitial readings can lag behind blood glucose during rapid change, symptoms that do not match the sensor may require a fingerstick check when it is safe and feasible. Predictive alarms and shared data can help another person intervene when the user is asleep, cognitively impaired, or unable to hear or act on an alarm.

Practical preparation may include:

  • fast-acting glucose in several reachable places;
  • prescribed glucagon that has not expired;
  • training for household members, coworkers, school staff, or travel companions;
  • backup glucose testing and insulin-delivery supplies;
  • a medical alert identifier;
  • an individualized plan for exercise, illness, vomiting, alcohol, and travel; and
  • placement of supplies where mobility, vision, dexterity, or cognitive changes do not make them inaccessible during a crisis.

Preparation supports independence. It does not transfer control of routine food, insulin, or activity decisions away from the person with diabetes.

Hyperglycemic emergencies

Diabetic ketoacidosis

DKA develops when there is not enough effective insulin and the body produces excessive ketones while breaking down fat for energy. Hyperglycemia, dehydration, electrolyte loss, and metabolic acidosis develop together. Infection, missed insulin, pump interruption, injury, and other acute illnesses can trigger it. It can also be the first presentation of Type 1 diabetes.

Symptoms may include intense thirst, frequent urination, nausea, vomiting, abdominal pain, weakness, fruity-smelling breath, deep rapid breathing, confusion, and reduced consciousness. Treatment requires emergency assessment, intravenous fluids, insulin, electrolyte management, and treatment of the precipitating cause. Insulin must not be withheld merely because a person with Type 1 diabetes is unable to eat.

Logan’s 2019 diagnosis followed months of thirst, frequent urination, fatigue, and weight loss before dangerously high glucose and A1C results confirmed Type 1 diabetes.

Hyperosmolar hyperglycemic state

HHS usually involves extreme hyperglycemia and dehydration with little or no major ketoacidosis. It is more common in Type 2 diabetes but can overlap with DKA. Both are hospital emergencies and cannot be treated as simple opposites of hypoglycemia.

Logan Weston’s hypoglycemia history

Logan Weston developed Type 1 diabetes at age eleven in 2019. He used an insulin pump and Dexcom CGM, carried rapid glucose, and built emergency preparation into his daily bags, home, vehicles, and workplaces. His ordinary management was meticulous. His most dangerous lows occurred when crisis, exertion, interrupted food intake, illness, or achievement pressure overwhelmed the attention he usually gave his body.

October 2024 school emergency

While Logan remained with Jacob Keller through a prolonged seizure in an Edgewood courtyard, Logan’s glucose fell to 38 mg/dL. He was shaking, sweating, cognitively impaired, and slurring his speech while still trying to direct care. Mr. Peterson accused him of intoxication. Paramedic Mike Rodriguez recognized the hypoglycemia, provided glucose treatment, and ensured Logan also received medical care. Logan received intravenous dextrose and overnight observation while Jacob remained critically ill.

Spring 2025 CCBC collapse

During a high-stakes presentation at CCBC Essex, Logan repeatedly silenced his Dexcom while his glucose fell from 63 to 54 mg/dL. His speech and notes stopped making sense, his hands shook, and he collapsed at the podium. Emergency personnel measured 48 mg/dL in the field. Intravenous glucose restored consciousness, but concurrent status migrainosus, severe dehydration, prolonged fasting, and a ketotic crisis required admission to UMMC Room 423. The event led Julia and Nathan to reduce his workload and stop accepting future promises that he would eat or rest after the work was finished.

December 2025 crisis call

At 2:00 a.m. on December 8, Logan called Charlie Rivera during an autistic meltdown compounded by urgent hypoglycemia. His Dexcom read 61 mg/dL with double-down arrows. Charlie reduced the number of steps Logan had to sequence and talked him through treating the low while also taking the emotional crisis seriously.

January 2035 Berlin hospital collapse

After performing more than six minutes of CPR during Ezra Cruz’s overdose and remaining awake through the hospital crisis, Logan continued to ignore his own food, rest, pain, and glucose needs. His glucose fell into an estimated 30–40 mg/dL range during the ICU vigil. He became shaky, dizzy, sweaty, visually impaired, and confused before losing consciousness on the ICU floor. Staff treated the severe hypoglycemia and monitored him through recovery.

Logan lost consciousness but did not enter a diabetic coma. Charlie, Peter, Riley, and Jacob returned to find him stable but still unresponsive during the early recovery period. He woke gradually with weakness, cognitive fog, headache, and intermittent sleep. The crisis unfolded separately from Ezra’s overdose treatment even though the exertion and prolonged vigil contributed to it.

Adult clinic near-coma

Years later, prolonged work and missed food produced another Level 3 event at Logan’s clinic. Charlie found him half-fallen from his wheelchair, barely conscious, unable to swallow, and reading 37 mg/dL with a downward trend. Charlie called emergency services and administered glucagon. Paramedics arrived within minutes, and Logan recovered after emergency treatment without entering a coma.

The event prompted stronger shared safeguards at the clinic and an intense public reaction from patients and staff who learned that Logan had nearly died. The safeguards added observation and reachable food without treating Logan as incapable of directing his ordinary care.

Shared access and care

Charlie learned Logan’s alarm patterns, kept glucagon and rapid carbohydrates accessible, and built Lolo’s Oh Shit Kit for travel and daily use. He also had access to Logan’s shared CGM data in adulthood. During severe events, this familiarity allowed him to recognize when conversation and oral glucose were no longer safe and emergency treatment was required.

After Logan’s spinal cord injury, altered sensation and autonomic responses made some bodily warning signs less dependable. His CGM therefore became more important, especially during sleep, illness, high pain, and intense work. The device was a safety aid rather than proof that every glucose change could be predicted or prevented.

Historical development

Before insulin treatment became available in 1922, Type 1 diabetes was usually fatal. Insulin made long-term survival possible while also creating a treatment-related risk of hypoglycemia. Early dosing relied on urine glucose and later intermittent blood testing. Home glucose meters, portable pumps, rapid- and long-acting insulin analogues, CGMs, data sharing, ready-to-use glucagon, and automated insulin-delivery systems gradually expanded both safety and autonomy.

Technology remains fallible and unequally available. Sensors can lag or fail, pump delivery can be interrupted, alarms can be missed, and insurance or cost barriers can restrict access. Competent emergency response therefore still depends on human recognition, reachable treatment, and belief when a disabled person says something is wrong.

Sources

  • American Diabetes Association. “Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes—2026.”
  • American Diabetes Association. “The Management of Type 1 Diabetes in Adults: A Consensus Report by the ADA and EASD.”
  • Centers for Disease Control and Prevention. “Low Blood Sugar (Hypoglycemia),” “Treatment of Low Blood Sugar,” and “Diabetic Ketoacidosis.”
Medical Conditions Metabolic Disorders Diabetic Emergencies